Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Comparing treatments for Trigger Finger using shock wave therapy and splints

Official title: Effectiveness of Conservative Interventions in the Treatment of Trigger Finger

Run by Hacettepe University · NCT06296017 · Data updated 2026-11-12

This study is testing whether shock wave therapy alone, shock wave therapy with splints, or just splints works best to relieve pain and improve function for people with Trigger Finger.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment54 (estimated)
SponsorHacettepe University
Academic / other
Locations1 site (Ankara)
StatusRecruiting
StartedOctober 2, 2025
Main results expectedMay 15, 2026
Study endsAugust 2027
Registry record updatedAugust 5, 2026
Trial IDNCT06296017 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18-65 diagnosed with stage 1 or stage 2 Trigger Finger.

Probably not a fit

Patients with inflammatory disorders, previous hand/wrist surgeries, or neurological diseases may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effectiveness of two conservative treatments for Trigger Finger: Extracorporeal Shock Wave Therapy (ESWT) and splint therapy. Patients diagnosed with stage 1 or stage 2 Trigger Finger will be randomly assigned to one of three groups: one receiving ESWT, another receiving ESWT combined with splint therapy, and a third receiving only splint therapy. The treatment's effectiveness will be evaluated through pain assessments and functional measurements at multiple time points. The study aims to provide evidence on the best conservative treatment approach for this condition.

Why it matters

Potential benefit: If successful, this study could provide patients with more effective treatment options for Trigger Finger, potentially reducing pain and improving hand function.

How similar studies have gone: While there is limited literature directly comparing ESWT and splint therapy for Trigger Finger, similar conservative treatment approaches have shown promise in other musculoskeletal conditions.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Volunteering
* Being between the ages of 18-65
* Being diagnosed with stage 1 or stage 2 (according to the Froimson classification) trigger finger
* Having the language and cognitive skills to answer the questionnaires used in the evaluation

Exclusion Criteria:

* Being pregnant
* Having an inflammatory disorder
* Having had surgery on the hand/wrist
* Having a neurological disease
* NSAIDs, painkillers, etc. being on medication
* De Quervain's tenosynovitis, carpal tunnel syndrome

Where it's running

  • Feray Karademir
    Ankara, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.